432 related articles for article (PubMed ID: 28551353)
1. The role of interleukin-1β as a predictive biomarker and potential therapeutic target during clinical ex vivo lung perfusion.
Andreasson ASI; Borthwick LA; Gillespie C; Jiwa K; Scott J; Henderson P; Mayes J; Romano R; Roman M; Ali S; Fildes JE; Marczin N; Dark JH; Fisher AJ;
J Heart Lung Transplant; 2017 Sep; 36(9):985-995. PubMed ID: 28551353
[TBL] [Abstract][Full Text] [Related]
2. Profiling inflammation and tissue injury markers in perfusate and bronchoalveolar lavage fluid during human ex vivo lung perfusion.
Andreasson AS; Karamanou DM; Gillespie CS; Özalp F; Butt T; Hill P; Jiwa K; Walden HR; Green NJ; Borthwick LA; Clark SC; Pauli H; Gould KF; Corris PA; Ali S; Dark JH; Fisher AJ
Eur J Cardiothorac Surg; 2017 Mar; 51(3):577-586. PubMed ID: 28082471
[TBL] [Abstract][Full Text] [Related]
3. Pro-IL-1β Is an Early Prognostic Indicator of Severe Donor Lung Injury During Ex Vivo Lung Perfusion.
Major T; Ball AL; Stone JP; Edge RJ; Lopez-Castejon G; Sjöberg T; Andreasson A; Brough D; Steen S; Fisher AJ; Fildes JE
Transplantation; 2021 Apr; 105(4):768-774. PubMed ID: 32976365
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo rehabilitation of non-heart-beating donor lungs in preclinical porcine model: delayed perfusion results in superior lung function.
Mulloy DP; Stone ML; Crosby IK; Lapar DJ; Sharma AK; Webb DV; Lau CL; Laubach VE; Kron IL
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1208-15. PubMed ID: 22944084
[TBL] [Abstract][Full Text] [Related]
5. Optimal ex vivo lung perfusion techniques with oxygenated perfusate.
Noda K; Tane S; Haam SJ; Hayanga AJ; D'Cunha J; Luketich JD; Shigemura N
J Heart Lung Transplant; 2017 Apr; 36(4):466-474. PubMed ID: 27914896
[TBL] [Abstract][Full Text] [Related]
6. An observational study of Donor Ex Vivo Lung Perfusion in UK lung transplantation: DEVELOP-UK.
Fisher A; Andreasson A; Chrysos A; Lally J; Mamasoula C; Exley C; Wilkinson J; Qian J; Watson G; Lewington O; Chadwick T; McColl E; Pearce M; Mann K; McMeekin N; Vale L; Tsui S; Yonan N; Simon A; Marczin N; Mascaro J; Dark J
Health Technol Assess; 2016 Nov; 20(85):1-276. PubMed ID: 27897967
[TBL] [Abstract][Full Text] [Related]
7. Lung Lavage and Surfactant Replacement During Ex Vivo Lung Perfusion for Treatment of Gastric Acid Aspiration-Induced Donor Lung Injury.
Nakajima D; Liu M; Ohsumi A; Kalaf R; Iskender I; Hsin M; Kanou T; Chen M; Baer B; Coutinho R; Maahs L; Behrens P; Azad S; Martinu T; Waddell TK; Lewis JF; Post M; Veldhuizen RAW; Cypel M; Keshavjee S
J Heart Lung Transplant; 2017 May; 36(5):577-585. PubMed ID: 28041954
[TBL] [Abstract][Full Text] [Related]
8. Technique for prolonged normothermic ex vivo lung perfusion.
Cypel M; Yeung JC; Hirayama S; Rubacha M; Fischer S; Anraku M; Sato M; Harwood S; Pierre A; Waddell TK; de Perrot M; Liu M; Keshavjee S
J Heart Lung Transplant; 2008 Dec; 27(12):1319-25. PubMed ID: 19059112
[TBL] [Abstract][Full Text] [Related]
9. The effects of hydrogen gas inhalation during ex vivo lung perfusion on donor lungs obtained after cardiac death.
Haam S; Lee S; Paik HC; Park MS; Song JH; Lim BJ; Nakao A
Eur J Cardiothorac Surg; 2015 Oct; 48(4):542-7. PubMed ID: 25750008
[TBL] [Abstract][Full Text] [Related]
10. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
Cypel M; Feld JJ; Galasso M; Pinto Ribeiro RV; Marks N; Kuczynski M; Kumar D; Bahinskaya I; Bagnato VS; Kurachi C; Slutsky AS; Yeung JC; Donahoe L; de Perrot M; Yasufuku K; Pierre A; Binnie M; Chaparro C; Martinu T; Chen M; Tikkanen J; Chow CW; Sidhu A; Waddell TK; Keshavjee S; Singer LG; Humar A
Lancet Respir Med; 2020 Feb; 8(2):192-201. PubMed ID: 31606437
[TBL] [Abstract][Full Text] [Related]
11. Standard donor lung procurement with normothermic ex vivo lung perfusion: A prospective randomized clinical trial.
Slama A; Schillab L; Barta M; Benedek A; Mitterbauer A; Hoetzenecker K; Taghavi S; Lang G; Matilla J; Ankersmit H; Hager H; Roth G; Klepetko W; Aigner C
J Heart Lung Transplant; 2017 Jul; 36(7):744-753. PubMed ID: 28314503
[TBL] [Abstract][Full Text] [Related]
12. Evaluating acellular versus cellular perfusate composition during prolonged ex vivo lung perfusion after initial cold ischaemia for 24 hours.
Becker S; Steinmeyer J; Avsar M; Höffler K; Salman J; Haverich A; Warnecke G; Ochs M; Schnapper A
Transpl Int; 2016 Jan; 29(1):88-97. PubMed ID: 26264867
[TBL] [Abstract][Full Text] [Related]
13. Protein expression profiling predicts graft performance in clinical ex vivo lung perfusion.
Machuca TN; Cypel M; Yeung JC; Bonato R; Zamel R; Chen M; Azad S; Hsin MK; Saito T; Guan Z; Waddell TK; Liu M; Keshavjee S
Ann Surg; 2015 Mar; 261(3):591-7. PubMed ID: 25371129
[TBL] [Abstract][Full Text] [Related]
14. Lungs donated after circulatory death and prolonged warm ischemia are transplanted successfully after enhanced ex vivo lung perfusion using adenosine A2B receptor antagonism.
Charles EJ; Mehaffey JH; Sharma AK; Zhao Y; Stoler MH; Isbell JM; Lau CL; Tribble CG; Laubach VE; Kron IL
J Thorac Cardiovasc Surg; 2017 Nov; 154(5):1811-1820. PubMed ID: 28483262
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo lung perfusion to improve donor lung function and increase the number of organs available for transplantation.
Valenza F; Rosso L; Coppola S; Froio S; Palleschi A; Tosi D; Mendogni P; Salice V; Ruggeri GM; Fumagalli J; Villa A; Nosotti M; Santambrogio L; Gattinoni L
Transpl Int; 2014 Jun; 27(6):553-61. PubMed ID: 24628890
[TBL] [Abstract][Full Text] [Related]
16. The role of the endothelin-1 pathway as a biomarker for donor lung assessment in clinical ex vivo lung perfusion.
Machuca TN; Cypel M; Zhao Y; Grasemann H; Tavasoli F; Yeung JC; Bonato R; Chen M; Zamel R; Chun YM; Guan Z; de Perrot M; Waddell TK; Liu M; Keshavjee S
J Heart Lung Transplant; 2015 Jun; 34(6):849-57. PubMed ID: 25907141
[TBL] [Abstract][Full Text] [Related]
17. Reduced-flow ex vivo lung perfusion to rehabilitate lungs donated after circulatory death.
Beller JP; Byler MR; Money DT; Chancellor WZ; Zhang A; Zhao Y; Stoler MH; Narahari AK; Shannon A; Mehaffey JH; Tribble CG; Laubach VE; Kron IL; Roeser ME
J Heart Lung Transplant; 2020 Jan; 39(1):74-82. PubMed ID: 31761511
[TBL] [Abstract][Full Text] [Related]
18. The Conversional Efficacy of Ex Vivo Lung Perfusion and Clinical Outcomes in Patients Undergoing Transplantation of Donor Lungs by Ex Vivo Lung Perfusion: A Meta-Analysis.
Luo Q; Zhu L; Wang Y; Wang L; Lv W; Hu J
Ann Transplant; 2019 Dec; 24():647-660. PubMed ID: 31879416
[TBL] [Abstract][Full Text] [Related]
19. Modeling the Effects of IL-1β-mediated Inflammation During Ex Vivo Lung Perfusion Using a Split Human Donor Model.
Pither T; Wang L; Bates L; Morrison M; Charlton C; Griffiths C; Macdonald J; Bigley V; Mavridou M; Barsby J; Borthwick L; Dark J; Scott W; Ali S; Fisher AJ
Transplantation; 2023 Oct; 107(10):2179-2189. PubMed ID: 37143202
[TBL] [Abstract][Full Text] [Related]
20. Effects of immediate versus delayed ex-vivo lung perfusion in a porcine cardiac arrest donation model.
Olbertz C; Pizanis N; Bäumker H; Becker S; Aigner C; Rauen U; Nolte I; Kamler M; Koch A
Int J Artif Organs; 2019 Jul; 42(7):362-369. PubMed ID: 31238824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
